Immuron Ltd
XMUN:ANW
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
I
|
Immuron Ltd
XMUN:ANW
|
AU |
|
I
|
Industrial and Commercial Bank of China Ltd
XMUN:ICK
|
CN |
Intrinsic Value
The intrinsic value of 
Immuron Ltd (ANW) under the Base Case is 0.254 EUR per share.
Compared with the current market price of 0.027 EUR, the stock appears
Undervalued by 89% .
The intrinsic value is calculated using valuation multiples.
Do our valuations actually work? See backtest results .
Cheap or expensive for this stock?
This block shows whether today’s valuation is cheap or expensive compared with the stock’s own history, and what happened after similar valuations in the past.
We compare the gap between the stock’s price and our estimated value over time.
- Undervalued can still be historically expensive. The stock may trade below our estimated value, but usually offer an even bigger discount.
- Overvalued can still be historically cheap. The stock may trade above our estimated value, but usually carry an even higher premium.
Market expectations can differ from our model, which may not fully capture everything affecting the price. That is why some stocks regularly trade above our estimated value and others below it.
The scale and chart show how today’s valuation compares with the past. The cards summarize past returns and waiting times until the stock stopped being cheap or expensive. This can happen because the price changed, our estimated value changed, or both.
Only completed periods are included. These are past results, not forecasts. The usual historical range does not necessarily mean fair value.
Fundamental Analysis
What Immuron Does
Immuron Ltd. is a biopharmaceutical company, which focuses on the development and commercialization of a novel class of specifically targeted polyclonal antibodies. The company operates through two segments: Research and development (R&D), and Hyperimmune products. The R&D segment is focused on R&D projects performed in Australia and the United States. Hyperimmune products segment is engaged in Travelan and Protectyn activities which occur predominantly in Australia, the United States and Canada.
- Headquarters
- Australia AU
- Employees
- 7
- IPO date
- Apr 30, 1999
Earnings Waterfall
Immuron Ltd
The intrinsic value for Immuron Ltd (ANW) under the Base Case is 0.254 EUR.
Compared with the current market price of 0.027 EUR, the stock appears Undervalued by 89% .